News

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
A man who was the first person in the UK to receive a groundbreaking gene-editing therapy on the NHS, said he felt " ...
Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...
Bacteria and their phage, “are full of mysteries and also lots of really powerful mechanisms that we can study and potentially harness.” ...
CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...
Intellia Therapeutics NTLA has put up a stellar performance in the past month. Shares of the company have rallied 29.8% compared with the industry’s rise of 0.4%. The stock has also outperformed the ...
Scientists at The Jackson Laboratory (JAX) have developed mouse models that survive premature death and enable pre-clinical ...
Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in comparison to traditional statin therapies. This is especially true for ...
Sangamo Therapeutics Inc. (NASDAQ:SGMO) ranks among the best CRISPR stocks to buy. Following the release of Sangamo ...
New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...
A new gene therapy trial safely restores hearing in deaf children and adults, offering hope for those with DFNB9 deafness ...
Melbourne scientists have shown for the first time how a “revolutionary” blood cancer treatment could be tweaked to also cure ...